Melatonin reduces dinitrobenzene sulfonic acid-induced colitis.
about
Melatonin reduces TNF-a induced expression of MAdCAM-1 via inhibition of NF-kappaBMatrix metalloproteinases in inflammatory bowel disease: an updateDNBS/TNBS colitis models: providing insights into inflammatory bowel disease and effects of dietary fat.Melatonin reduces oxidant damage and promotes mitochondrial respiration: implications for aging.Melatonin and ulcerative colitis: evidence, biological mechanisms, and future research.Melatonin reduces inflammatory injury through inhibiting NF-kappaB activation in rats with colitis.Effects of antioxidant therapy on leukocyte myeloperoxidase and Cu/Zn-superoxide dismutase and plasma malondialdehyde levels in experimental colitisMilk fat globule-EGF factor 8 is a critical protein for healing of dextran sodium sulfate-induced acute colitis in mice.Distribution, function and physiological role of melatonin in the lower gut.Melatonin as an organoprotector in the stomach and the pancreas.Hyperhomocysteinemia decreases intestinal motility leading to constipation.Melatonin improves experimental colitis with sleep deprivationMelatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice.Melatonin: buffering the immune systemModulation by melatonin of the pathogenesis of inflammatory autoimmune diseases.Melatonin modulates adiponectin expression on murine colitis with sleep deprivation.The effect of melatonin on endothelial dysfunction in patient undergoing coronary artery bypass grafting surgeryPharmacological strategies against cold ischemia reperfusion injury.New paradigms in chronic intestinal inflammation and colon cancer: role of melatonin.A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives.New targeting strategies in drug therapy of inflammatory bowel disease: mechanistic approaches and opportunities.A review of the use of melatonin in ulcerative colitis: experimental evidence and new approaches.Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review.The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases.Anti-inflammatory effects of melatonin in multiple sclerosis.Gut melatonin response to microbial infection in carp Catla catla.Effects of melatonin on the expression of iNOS and COX-2 in rat models of colitis.Change of nitric oxide in experimental colitis and its inhibition by melatonin in vivo and in vitro.Evaluation of enterochromaffin cells and melatonin secretion exponents in ulcerative colitis.Melatonin for ulcerative colitis?Melatonin reduces ulcerative colitis-associated local and systemic damage in mice: investigation on possible mechanisms.Exposure to continuous darkness ameliorates gastric and colonic inflammation in the rat: both receptor and non-receptor-mediated processes.The effect of melatonin on plasma markers of inflammation and on expression of nuclear factor-kappa beta in acetic acid-induced colitis in the rat.Effect of endogen-exogenous melatonin and erythropoietin on dinitrobenzene sulfonic acid-induced colitis.Protective effect of melatonin on Ca2+ homeostasis and contractility in acute cholecystitis.Acutely administered melatonin is beneficial while chronic melatonin treatment aggravates the evolution of TNBS-induced colitis.Melatonin expresses powerful anti-inflammatory and antioxidant activities resulting in complete improvement of acetic-acid-induced colitis in rats.Melatonin attenuates dextran sodium sulfate induced colitis with sleep deprivation: possible mechanism by microarray analysis.Alterations in melatonin and serotonin signalling in the colonic mucosa of mice with dextran-sodium sulfate-induced colitis.Heterogeneous expression of melatonin receptor MT1 mRNA in the rat intestine under control and fasting conditions.
P2860
Q24790971-CB8DDAAF-65DC-48F0-82AF-BD59654E9612Q28080664-A1FA449C-7788-4036-BF00-A5FAABC1BABAQ34074937-8FED6EB8-DB06-41E2-A144-6025BD73353CQ34614504-16BF65FE-0E4C-4334-BE6C-BF45BAD82657Q34796036-ED7243BC-78A6-4BF1-BDC8-76A0C2D55055Q34894637-B4792173-6FE2-440C-BDF6-92A0627A5EF9Q34945561-0B03A2D1-DF9F-46D8-9410-C5E13280568EQ35016993-236D14EC-8B07-4C12-8DB1-ECE58FEDDC00Q35404204-0C96786B-FB3D-41E1-A577-AE92D7836537Q36025885-C378406B-86DA-4A07-8F7F-0BDF19CFE085Q36175923-7458DF4B-994F-46E6-B2F8-A4DFFF015CEDQ36528129-BF321A3B-9257-40DA-B03E-5454BCB8C3C8Q36772909-DA55F8BF-1D24-4FB5-B453-0D628A0AC90DQ36820644-BDEA249F-B95A-45FD-B444-B4F39C756EFCQ37007219-7FC37E96-A12F-4BDE-BD25-636802840D0AQ37232711-A125AAFE-6975-4A53-A453-73401E213562Q37504626-7C7D6070-6195-4BCD-B439-1A534B57796AQ37693921-BC3E55DA-D997-4AF8-A60C-49AFDF94D743Q37900677-086F4D3E-8233-40B5-8169-BBD8566D5DE6Q38020932-ABA76239-F364-4424-85CF-494FBFE87B66Q38110619-0927A4EE-A9B6-4F3C-BDCF-A36C49600656Q38163844-9EE48F20-1FAE-414B-8992-9D63697A06D5Q38191261-D2A15681-E06B-47D4-9B38-AD5C663EB28DQ38881849-54508510-36EA-47C6-B938-037E198028E6Q38937138-A159A52D-C172-47B6-AA68-9784EEE5129BQ40326907-BA18843F-2202-4BCB-A982-7A44699F68E9Q41904590-602B3DC6-A489-4506-A789-B9F3D95CBCBFQ42099871-592BE507-7EF1-4DEC-8699-608B7981479DQ42276526-5B25DFB4-A735-4B7E-AA42-D5A70DB4D9C7Q44277510-15A4DAB7-0DBA-4AE5-9D49-B3A3216E5B3BQ44731673-C0833623-2610-4188-AFD9-04802C962AC4Q45245823-631D7929-2FA7-455C-BD1F-87489BA3897AQ46343201-A62F951A-D534-4407-9024-47E41D927AD7Q46381876-AAE23E16-920B-4248-B10A-6525A05D42F6Q46703459-07D17172-4DD0-4380-812E-7E31390ACFD2Q46824354-AB3EC26E-425B-41BB-9A1E-C60A1238163AQ47608127-9E6D00A2-BFB5-46B6-96BB-0E7E96B84172Q48131428-88EDAD75-38C8-4239-8317-FC2020F3FBC9Q49977000-0E57EDBD-CC18-4A00-9702-D048A7A3B5BEQ51493403-8EEBA242-1140-4917-A38E-12B1D37C6EFF
P2860
Melatonin reduces dinitrobenzene sulfonic acid-induced colitis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Melatonin reduces dinitrobenzene sulfonic acid-induced colitis.
@ast
Melatonin reduces dinitrobenzene sulfonic acid-induced colitis.
@en
type
label
Melatonin reduces dinitrobenzene sulfonic acid-induced colitis.
@ast
Melatonin reduces dinitrobenzene sulfonic acid-induced colitis.
@en
prefLabel
Melatonin reduces dinitrobenzene sulfonic acid-induced colitis.
@ast
Melatonin reduces dinitrobenzene sulfonic acid-induced colitis.
@en
P2093
P1476
Melatonin reduces dinitrobenzene sulfonic acid-induced colitis.
@en
P2093
Cuzzocrea S
Serraino I
Terranova ML
P356
10.1034/J.1600-079X.2001.300101.X
P577
2001-01-01T00:00:00Z